Jennifer Young
Physician Assistant · Atlanta, GANPI 1093063380
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $21,487 of the $31,687 with a category attached, or 67.8%. 33 manufacturers reported payments, led by Amgen at 37.5% of the total. Reporting peaked in 2022 at $10,045 and has fallen 67.4% since, to $3,271 in 2025. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,043 payments — averaging $30.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$12K
- AbbVie$7K
- UCB, Inc.$3K
- Novartis$2K
- Johnson & Johnson$2K
- AstraZeneca$1K
- plus $5K from 27 others
What the payments were for
- Consulting fees$1,1404%
- Speaking & faculty fees$7,05022%
- Travel & lodging$1,6475%
- Food & beverage$21,48768%
- Education$3631%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 152 | $11,877 |
| AbbVie | 304 | $7,049 |
| UCB, Inc. | 110 | $3,040 |
| Novartis | 139 | $2,165 |
| Johnson & Johnson(2 entities) | 69 | $1,799 |
| AstraZeneca(2 entities) | 41 | $1,121 |
| Pfizer | 49 | $737 |
| GSK | 25 | $513 |
| Mallinckrodt Hospital Products Inc. | 17 | $470 |
| ANI Pharmaceuticals, Inc. | 16 | $360 |
| Boehringer Ingelheim | 12 | $334 |
| Aurinia Pharma U.S., Inc. | 18 | $328 |
| Radius Health, Inc. | 13 | $294 |
| Lilly USA, LLC | 14 | $277 |
| Organon | 10 | $212 |
| E.r. Squibb & Sons, L.L.C. | 10 | $179 |
| Genentech USA, Inc. | 7 | $125 |
| Octapharma USA, Inc. | 4 | $121 |
| Sumitomo Pharma America, Inc. | 5 | $101 |
| Sandoz | 5 | $99 |
| Sanofi | 3 | $79 |
| Janssen Scientific Affairs, LLC | 1 | $51 |
| Fresenius Kabi USA, LLC | 3 | $46 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $45 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $41 |
| Sobi, Inc | 2 | $36 |
| Scilex Pharmaceuticals Inc. | 2 | $36 |
| Eisai Inc. | 1 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $31 |
| Invivyd Inc | 1 | $25 |
| Boston Scientific | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 2 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,687 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 58 | $399,988 |
| Enbrel SureclickEtanercept | 45 | $329,474 |
| OtezlaApremilast | 51 | $257,616 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 26 | $187,218 |
| XeljanzTofacitinib Citrate | 33 | $187,106 |
| Humira(Cf) PenAdalimumab | 18 | $122,342 |
| Cosentyx Unoready PenSecukinumab | 12 | $97,801 |
| Actemra ActpenTocilizumab | 12 | $54,821 |
| Hydroxychloroquine Sulfate | 192 | $11,796 |
| Cevimeline Hcl | 44 | $10,925 |
| Leflunomide | 87 | $5,847 |
| MethotrexateMethotrexate Sodium | 185 | $4,652 |
| Mycophenolate Mofetil | 44 | $3,680 |
| Gabapentin | 145 | $3,375 |
| Pilocarpine Hcl | 33 | $2,688 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $7,049 | $399,98858 claims |
| AmgenOtezla | $11,877 | $257,61651 claims |
| PfizerXeljanz | $737 | $187,10633 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $36 | $1,14726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Jaime AckermanAtlanta$84K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Kia CampbellAtlanta$20K
- Laura GillespieAtlanta$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.